Profile
Birgitte Skou Holck-Andersen is a Director of ACE BioSciences A/S and NatImmune A/S and Deputy Chairman of ZGene A/S.
She is an Investment Manager of A/S Dansk Erhvervsinvestering.
Dr. Holck-Andersen joined A/S Dansk Erhvervsinvestering in 2001.
She has 10 years of experience in the biotech and healthcare industries.
Dr. Holck-Andersen received an MSc degree in 1984 and a PhD in 1987 from the Technical University of Denmark.
Former positions of Birgitte Skou Holck-Andersen
| Companies | Position | End |
|---|---|---|
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Director/Board Member | - |
ACE BioSciences ApS
 ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Director/Board Member | - |
Training of Birgitte Skou Holck-Andersen
| Technical University of Denmark | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ACE BioSciences ApS
ACE BioSciences ApS Pharmaceuticals: MajorHealth Technology ACE BioSciences A/S engages in the research and experimental development on biotechnology. It offers medical research, production, and sale of medical products. The company was founded on September 15, 2000 and is headquartered in Hillerød, Denmark. | Health Technology |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
- Stock Market
- Insiders
- Birgitte Skou Holck-Andersen
